PDB Short entry for 2QQ7 HEADER TRANSFERASE 26-JUL-07 2QQ7 TITLE CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH TITLE 2 IRREVERSIBLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN; COMPND 5 SYNONYM: P60-SRC, C-SRC, PP60C-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSKB3 KEYWDS SRC KINASE DOMAIN, DRUG RESISTANCE, IRREVERSIBLE INHIBITOR, KEYWDS 2 ALTERNATIVE SPLICING, ATP-BINDING, LIPOPROTEIN, MYRISTATE, KEYWDS 3 NUCLEOTIDE-BINDING, PHOSPHORYLATION, PROTO-ONCOGENE, SH2 DOMAIN, SH3 KEYWDS 4 DOMAIN, TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR A.MICHALCZYK,H.B.RODE,C.GRUETTER,D.RAUH REVDAT 5 20-OCT-21 2QQ7 1 REMARK SEQADV LINK REVDAT 4 24-FEB-09 2QQ7 1 VERSN REVDAT 3 01-JUL-08 2QQ7 1 JRNL REVDAT 2 18-MAR-08 2QQ7 1 JRNL REVDAT 1 11-MAR-08 2QQ7 0 JRNL AUTH A.MICHALCZYK,S.KLUTER,H.B.RODE,J.R.SIMARD,C.GRUTTER, JRNL AUTH 2 M.RABILLER,D.RAUH JRNL TITL STRUCTURAL INSIGHTS INTO HOW IRREVERSIBLE INHIBITORS CAN JRNL TITL 2 OVERCOME DRUG RESISTANCE IN EGFR. JRNL REF BIOORG.MED.CHEM. V. 16 3482 2008 JRNL REFN ISSN 0968-0896 JRNL PMID 18316192 JRNL DOI 10.1016/J.BMC.2008.02.053 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 29935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1518 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2078 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.15 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 94 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3925 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.49000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : -0.34000 REMARK 3 B12 (A**2) : 0.08000 REMARK 3 B13 (A**2) : -0.38000 REMARK 3 B23 (A**2) : 0.60000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.310 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.248 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.157 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.375 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.888 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4088 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5542 ; 1.841 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 490 ; 8.240 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 178 ;38.219 ;23.539 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 688 ;17.903 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;17.936 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3088 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1975 ; 0.224 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2708 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 212 ; 0.206 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.214 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.255 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2535 ; 1.006 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3964 ; 1.736 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1846 ; 2.415 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1576 ; 3.717 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2QQ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-07. REMARK 100 THE DEPOSITION ID IS D_1000043917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9998 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29936 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 73.565 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 2.100 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.06900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.12600 REMARK 200 R SYM FOR SHELL (I) : 0.12600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% ETHYLENE GLYCOL, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 CYS A 277 REMARK 465 LYS A 298 REMARK 465 PRO A 299 REMARK 465 GLY A 300 REMARK 465 THR A 301 REMARK 465 MET A 302 REMARK 465 SER A 303 REMARK 465 PRO A 304 REMARK 465 GLU A 305 REMARK 465 ALA A 306 REMARK 465 PHE A 307 REMARK 465 LEU A 308 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 PHE A 424 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 ALA B 256 REMARK 465 LYS B 257 REMARK 465 CYS B 277 REMARK 465 PHE B 278 REMARK 465 PRO B 299 REMARK 465 GLY B 300 REMARK 465 THR B 301 REMARK 465 MET B 302 REMARK 465 SER B 303 REMARK 465 PRO B 304 REMARK 465 GLU B 305 REMARK 465 ALA B 306 REMARK 465 PHE B 307 REMARK 465 LEU B 308 REMARK 465 GLN B 309 REMARK 465 GLU B 310 REMARK 465 ALA B 311 REMARK 465 ALA B 408 REMARK 465 ARG B 409 REMARK 465 LEU B 410 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 465 PHE B 424 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 272 CE NZ REMARK 470 GLN A 275 CG CD OE1 NE2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 LEU A 297 CG CD1 CD2 REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 SER A 330 OG REMARK 470 GLU A 332 CG CD OE1 OE2 REMARK 470 LEU A 407 CG CD1 CD2 REMARK 470 ARG A 409 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 410 CG CD1 CD2 REMARK 470 ASP A 473 CG OD1 OD2 REMARK 470 GLU A 504 CG CD OE1 OE2 REMARK 470 GLN A 526 CG CD OE1 NE2 REMARK 470 ARG B 268 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 272 CE NZ REMARK 470 LEU B 297 CG CD1 CD2 REMARK 470 LYS B 316 CG CD CE NZ REMARK 470 GLU B 332 CG CD OE1 OE2 REMARK 470 ASP B 473 CG OD1 OD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLY A 284 C REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 431 C - N - CA ANGL. DEV. = 10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 270 -64.95 -128.03 REMARK 500 ALA A 311 106.32 -46.99 REMARK 500 GLN A 312 -63.21 168.20 REMARK 500 VAL A 313 -124.89 55.95 REMARK 500 MET A 314 -6.45 -51.72 REMARK 500 SER A 330 -42.48 -29.18 REMARK 500 GLU A 331 88.23 -156.50 REMARK 500 ARG A 385 -18.16 92.76 REMARK 500 ASP A 386 46.16 -140.25 REMARK 500 GLU A 486 -5.83 75.11 REMARK 500 THR A 523 -57.41 -121.75 REMARK 500 LEU B 273 -48.61 -139.75 REMARK 500 GLN B 275 152.66 171.82 REMARK 500 ASN B 287 -140.09 59.16 REMARK 500 LYS B 315 133.17 -174.98 REMARK 500 SER B 330 46.83 -103.74 REMARK 500 GLU B 331 -83.59 -133.27 REMARK 500 ARG B 385 -16.08 85.98 REMARK 500 ASP B 386 54.11 -148.15 REMARK 500 ASP B 404 -10.12 -160.38 REMARK 500 PHE B 405 -18.85 -153.22 REMARK 500 GLU B 486 -2.02 67.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 310 ALA A 311 135.84 REMARK 500 GLN A 312 VAL A 313 51.63 REMARK 500 SER A 330 GLU A 331 -66.14 REMARK 500 LEU B 273 GLY B 274 80.51 REMARK 500 LYS B 315 LYS B 316 38.18 REMARK 500 LYS B 316 LEU B 317 111.16 REMARK 500 VAL B 402 ALA B 403 135.44 REMARK 500 ALA B 403 ASP B 404 60.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SR2 A 1345 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SR2 B 1345 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2HWP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT REMARK 900 INHIBITOR PD168393 REMARK 900 RELATED ID: 2QLQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SRC KINASE WITH COVALENT INHIBITOR REMARK 900 RELATED ID: 2QIG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SRC KINASE WITH COVALENT INHIBITOR PD168393 REMARK 900 RELATED ID: 2QI8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN DBREF 2QQ7 A 251 533 UNP P00523 SRC_CHICK 251 533 DBREF 2QQ7 B 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 2QQ7 GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 MET A 250 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 MET A 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 2QQ7 CYS A 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQADV 2QQ7 GLY B 248 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 HIS B 249 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 MET B 250 UNP P00523 EXPRESSION TAG SEQADV 2QQ7 MET B 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 2QQ7 CYS B 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 A 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 B 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET SR2 A1345 27 HET SR2 B1345 27 HETNAM SR2 (2E)-N-{4-[(3-BROMOPHENYL)AMINO]QUINAZOLIN-6-YL}-4- HETNAM 2 SR2 (DIMETHYLAMINO)BUT-2-ENAMIDE FORMUL 3 SR2 2(C20 H20 BR N5 O) FORMUL 5 HOH *168(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 GLN A 309 MET A 314 1 6 HELIX 3 3 LEU A 346 GLY A 352 1 7 HELIX 4 4 ARG A 359 MET A 380 1 22 HELIX 5 5 ARG A 388 ALA A 390 5 3 HELIX 6 6 GLU A 396 LEU A 398 5 3 HELIX 7 7 ASP A 404 ALA A 408 5 5 HELIX 8 8 ALA A 430 GLY A 437 1 8 HELIX 9 9 THR A 440 THR A 457 1 18 HELIX 10 10 VAL A 467 ARG A 477 1 11 HELIX 11 11 PRO A 488 TRP A 499 1 12 HELIX 12 12 ASP A 502 ARG A 506 5 5 HELIX 13 13 THR A 508 ASP A 518 1 11 HELIX 14 14 ASP A 518 THR A 523 1 6 HELIX 15 15 PRO B 263 GLU B 265 5 3 HELIX 16 16 CYS B 345 GLY B 352 1 8 HELIX 17 17 MET B 354 LEU B 358 5 5 HELIX 18 18 ARG B 359 MET B 380 1 22 HELIX 19 19 ARG B 388 ALA B 390 5 3 HELIX 20 20 GLU B 396 LEU B 398 5 3 HELIX 21 21 ALA B 430 GLY B 437 1 8 HELIX 22 22 THR B 440 THR B 457 1 18 HELIX 23 23 VAL B 467 ARG B 477 1 11 HELIX 24 24 PRO B 488 TRP B 499 1 12 HELIX 25 25 THR B 508 ASP B 518 1 11 HELIX 26 26 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 LYS A 272 0 SHEET 2 A 5 VAL A 281 TRP A 286 -1 O MET A 283 N GLU A 270 SHEET 3 A 5 THR A 290 THR A 296 -1 O ILE A 294 N TRP A 282 SHEET 4 A 5 TYR A 335 MET A 338 -1 O ILE A 336 N LYS A 295 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 B 3 GLY A 344 CYS A 345 0 SHEET 2 B 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 B 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 5 LEU B 267 GLY B 274 0 SHEET 2 C 5 GLU B 280 TRP B 286 -1 O VAL B 281 N GLY B 274 SHEET 3 C 5 THR B 290 THR B 296 -1 O THR B 290 N TRP B 286 SHEET 4 C 5 TYR B 335 MET B 338 -1 O ILE B 336 N LYS B 295 SHEET 5 C 5 LEU B 325 VAL B 329 -1 N ALA B 327 O VAL B 337 SHEET 1 D 2 ILE B 392 VAL B 394 0 SHEET 2 D 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 LINK SG CYS A 345 C51 SR2 A1345 1555 1555 1.86 LINK SG CYS B 345 C51 SR2 B1345 1555 1555 1.87 CISPEP 1 LEU A 273 GLY A 274 0 -5.59 CISPEP 2 GLN A 275 GLY A 276 0 0.20 CISPEP 3 GLU A 332 PRO A 333 0 13.96 CISPEP 4 ARG A 409 LEU A 410 0 26.09 CISPEP 5 GLN B 275 GLY B 276 0 -0.94 CISPEP 6 VAL B 313 MET B 314 0 13.17 CISPEP 7 MET B 314 LYS B 315 0 26.79 CISPEP 8 GLU B 332 PRO B 333 0 -22.47 CISPEP 9 ASP B 404 PHE B 405 0 27.07 SITE 1 AC1 12 HOH A 137 ALA A 293 LYS A 295 GLU A 310 SITE 2 AC1 12 ILE A 336 MET A 338 MET A 341 GLY A 344 SITE 3 AC1 12 CYS A 345 ASP A 348 LEU A 393 ASP A 404 SITE 1 AC2 12 SER A 522 HOH B 133 HOH B 214 ALA B 293 SITE 2 AC2 12 LYS B 295 MET B 341 GLY B 344 CYS B 345 SITE 3 AC2 12 ASP B 348 ALA B 390 LEU B 393 PHE B 405 CRYST1 42.220 63.360 75.060 78.58 89.08 89.87 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023685 -0.000054 -0.000377 0.00000 SCALE2 0.000000 0.015783 -0.003188 0.00000 SCALE3 0.000000 0.000000 0.013593 0.00000